MSF Access Campaign
This #Ebola disease outbreak once again exposes persistent failures to ensure that accessible medical tools for diseases disproportionately affecting low- and middle-income countries are prioritise...
In 2024, half of the 14.3 million children who missed out on receiving any vaccination lived in countries affected by conflict, fragility, or humanitarian crises. It's time to close this gap throug...
Each year, over a quarter of a million children acquire chronic hepatitis B at birth, resulting in many premature deaths.
If every newborn received hepatitis B birth dose – an affordable vaccine ...
Neglected diseases are estimated to affect more than 1 billion people. However, there's limited attention and funding into vaccine research & development for these diseases. Safe & effective v
Investing in innovations like vaccine Microarray Patches could help overcome barriers to reaching people in remote, conflict-affected, and fragile settings with vaccination.
#WorldImmunisationWee...
Tuberculosis continues to kill more than 1 million people each year.
A safe, effective, and affordable vaccine to protect adolescents and adults against #tuberculosis would be a significant step...
On 19 February 2026, Médecins Sans Frontières (MSF) Access convened leading experts to discuss the broader implications of declining research and development (R&D) funding across the African conti
On World Children’s Day (20 Nov 2025), TB activists and MSF marched in solidarity with children affected by tuberculosis at the Union World Conference on Lung Health in Copenhagen. To learn more ab...
As part of World AMR Awareness Week (18-24 November 2025), the AMR Multi-Stakeholder Partnership Platform and Médecins Sans Frontières (MSF) convened an important dialogue: Antimicrobial resistance...
1.2 million children and young adolescents fell ill in 2024, and a staggering 43% were never diagnosed and thus missed lifesaving treatment. Act now to close the deadly gap!
Tuberculosis (TB) remains the world’s deadliest infectious disease, despite being curable. In 2023, an estimated 1.3 million children and young adolescents fell ill with TB, accounting for 12% of a...
Brussels, 14 October 2025: Although tuberculosis (TB) is both preventable and curable, people with TB across Europe continue to face unnecessary suffering due to limited access to effective treatme...
This video explores the medical advances that transformed MSF medical care approaches a decade ago — and the urgent innovations still needed today to tackle diabetes in the low and middle income co...
Millions of people with diabetes rely on insulin to stay alive and healthy.
In South Africa, where diabetes is a leading cause of death, human insulin has been available in pens since 2014.
For m...
A trio of stories featuring three people living with diabetes who have made difficult journeys to Greece while trying to manage their illness.
Amina was dealing with an abusive and violent husband while coping with one of her sons' diabetes. Fearing for her children’s lives, she decided to flee. Reaching Europe safely, along with securing...
Anis and his family had to flee Syria after they lost everything in the war. The journey was hard, especially since they had their newborn baby with them, and Anis was diagnosed with #diabetes whil...
Ghassan has type 2 #diabetes. He managed it with a strict treatment routine for 15+ years. However, when he and his family left Gaza in September 2023, to seek safety in Europe, he faced many chall...
At the webinar, MSF teams presented the data from the report, TACTIC: Test, Avoid, Cure TB in Children that surveyed in 14 countries* looking into national policies in diagnosing, preventing and t...
The Access Campaign (AC) was created in 1999 by MSF and is multi-disciplinary unit within the movement. The AC works closely with our operations to find ways to overcome the barriers that stop our ...